2Y01

turkey beta1 adrenergic receptor with stabilising mutations and bound partial agonist dobutamine (crystal dob102)

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 85
  • Norm. En. per Res.: -0.9189
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	0.0	19.4158	-97.5234	-78.1076	85	1	9	5423	0	7	4

Interface residues

• A-B: ALA167A, ALA167B, ALA170A, ALA170B, ALA206A, ALA206B, ALA210A, ALA210B, ARG148A, ARG148B, ARG157A, ARG157B, ARG205A, ARG205B, ARG317A, ASN204A, ASN204B, ASN316B, CYS163A, CYS163B, GLU130A, GLU130B, GLU185B, ILE137A, ILE137B, ILE161A, ILE161B, ILE168A, ILE168B, ILE177A, ILE177B, ILE209A, ILE209B, ILE213A, ILE213B, ILE214A, ILE214B, ILE218A, ILE218B, ILE222A, ILE222B, LEU141A, LEU141B, LEU152A, LEU152B, LEU171A, LEU171B, LEU175A, LEU175B, LEU221A, LEU221B, MET178A, MET179A, MET179B, PHE174A, PHE174B, PHE225A, PHE315A, PHE315B, PRO176A, PRO176B, PRO219A, PRO219B, SER169A, SER169B, SER173A, SER173B, SER211A, SER211B, THR164A, THR164B, TRP166A, TRP166B, TRP181A, TRP181B, TYR207A, TYR207B, VAL160A, VAL160B, VAL165A, VAL165B, VAL172A, VAL172B, VAL314A, VAL314B